Next Article in Journal
Decline of Anti-SARS-CoV-2 IgG Antibody Levels 6 Months after Complete BNT162b2 Vaccination in Healthcare Workers to Levels Observed Following the First Vaccine Dose
Next Article in Special Issue
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
Previous Article in Journal
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
Previous Article in Special Issue
Impact of Molecular Modifications on the Immunogenicity and Efficacy of Recombinant Raccoon Poxvirus-Vectored Rabies Vaccine Candidates in Mice
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 152; https://doi.org/10.3390/vaccines10020152
Action Date Notes Link
article xml file uploaded 20 January 2022 12:42 CET Original file -
article xml uploaded. 20 January 2022 12:42 CET Update https://www.mdpi.com/2076-393X/10/2/152/xml
article pdf uploaded. 20 January 2022 12:42 CET Version of Record https://www.mdpi.com/2076-393X/10/2/152/pdf
article html file updated 20 January 2022 12:43 CET Original file -
article html file updated 31 July 2022 04:56 CEST Update https://www.mdpi.com/2076-393X/10/2/152/html
Back to TopTop